CanFinis Therapeutics Pvt., Ltd.

CanFinis Therapeutics, an oncology research and cell therapy start-up based in Kolkata, was founded by leading technology experts, entrepreneurs, and clinicians. The company has developed an innovative tumor microenvironment platform that tests the efficacy of both standard care drugs and novel molecules ex vivo at the preclinical stage. This platform is utilized by oncology drug discovery companies. Additionally, CanFinis is working on pioneering CAR-T therapies targeting solid tumors prevalent in India and Southeast Asia. The company is poised for a potential collaboration to develop and commercialize a novel CAR-T product in India and Southeast Asia. CanFinis aims to enhance CAR-T therapies by leveraging a deep understanding of patient tumor antigens to optimize treatments, reduce time, and cut costs. With its advanced tumor microenvironment platform and CAR-T innovations, CanFinis is set to transform patient care and establish a significant market for personalized cancer treatments by integrating global talent and technologies.